Chelsey O Chen

7PUBLICATIONS
122CO-AUTHORS
Predictive and prognostic markersCancer cell biologyTumour immunologyHaematological tumoursMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 06, 2026
Targeting conserved domains of hypoxia-inducible factors for cancer therapy.

Shaima Salman, Tina Y Huang, Yousang Hwang

|Dec 12, 2025
HIF-1-mediated ISG20 expression promotes breast cancer stemness and immune evasion.

Yongkang Yang, Qiaozhu Zuo, Vijay Ramu

|Apr 23, 2025
Intrinsic Properties of the Lymph Node Render It Immunologically Susceptible to Metastasis.

Benjamin M Kahn, Raymond W S Ng, Il-Kyu Kim

|Jun 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori

|Dec 09, 2022
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification.

Yongkang Yang, Chelsey Chen, Qiaozhu Zuo

|Aug 28, 2021
Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization.

Yufeng Wang, Yajing Lyu, Kangsheng Tu

Pageof 2

Frequent Collaborators

4 joint publications

Yajing Lyu

4 joint publications

Gregg L Semenza

3 joint publications

Yufeng Wang

3 joint publications

Elizabeth E Wicks